trending Market Intelligence /marketintelligence/en/news-insights/trending/hxpeluhcbdy4f4jjgg-z_g2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Interleukin board member to resign

Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense

Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures

MA Activity The Big Story In Mature Online Video Platform Market

Martina Cheung Backs The Quality Program


Interleukin board member to resign

Roger Colman is resigning from the Interleukin Genetics Inc. board on Dec. 30.

He was nominated by Pyxis Innovations Inc. following an investment in Interleukin Genetics. Colman is also retiring from Pyxis.

Pyxis Innovations can appoint two directors to the Interleukin Genetics board but is waiving off its right to name a replacement for Colman.

Joseph Landstra continues to represent Pyxis on the Interleukin board.